Difference-weighted somatic spectroscopy

• US 20080009689A1
• Filed: 06/20/2007
• Published: 01/10/2008
• Est. Priority Date: 04/09/2002
• Status: Abandoned Application

• Current Assignee: JB IP Acquisitions LLC
• Original Assignee: JB IP Acquisitions LLC
• Inventors: Fierro, Michael, Benaron, David, Parachikov, Illian
• Application Number:
  US11/820,809
• Publication Number:
  US 20080009689A1
• Time in Patent Office: Days
• US Class Current: 600/323
• CPC Class Codes: A61B 5/0261 using optical means, e.g. infrared light
• CPC Class Codes: A61B 5/14551 for measuring blood gases

Abstract

An ischemia detection system in two or more somatic measures, collected simultaneously or near-simultaneously, are provided for direct or computational comparison, in which light from light source A (103A) and source B (103B) is detected by a sensor (155), and a difference-weighted value is determined (167), thereby enhancing the value of the spectroscopic measurements over values taken individually and singly.

Claims

1. A difference-weighted spectroscopic somatic monitoring apparatus comprising:

a first sensor configured to generate, based upon light produced and/or detected by said first sensor, a first somatic output signal that is a function of a first spectroscopic measurement of a first somatic target site;

a second sensor configured to generate, based upon light produced and/or detected by said second sensor, a second somatic output signal that is a function of a second spectroscopic measurement of a second somatic target site; and

,

a difference unit configured to compare said first and second somatic signals, and to generate a difference-weighted output signal based upon said comparison.

2. The apparatus of claim 1 wherein said difference unit is configured to perform a computational comparison of said first and second somatic signals.

3. The apparatus of claim 1 further comprising a display configured to display said first and second somatic signals and allow for direct, mutual, and simultaneous or near-simultaneous inspection of said first and second somatic signals.

4. The apparatus of claim 1 wherein said first somatic signal is a first oximetry value, and said second somatic signal is a second oximetry value and said difference-weighted signal is a function of a weighted subtraction of said first and second oximetry values.

5. The apparatus of claim 1 wherein said first somatic signal is an arterial oximetry estimate, said second somatic signal is a capillary oximetry estimate, and said difference-weighted signal is a function of the arteriovenous difference based upon a weighted subtraction of said first and second oximetry values.

6. The apparatus of claim 1 wherein said first signal is a first optical spectrum, and said second signal is a second optical spectrum, and said difference-weighted signal is a function of a weighted subtraction of said first and second spectra.

7. The apparatus of claim 6 wherein said first spectrum is a systolic spectrum, said second spectrum is a diastolic spectrum, and said difference-weighted signal is a function of an arteriovenous difference estimated from said first and second spectra.

8. The apparatus of claim 1 wherein said difference-weighted output signal is a measure of the presence, absence, or degree of ischemia.

9. The apparatus of claim 1 wherein said difference-weighted output signal is a measure of the presence, absence, or degree of cancer.

10. The apparatus of claim 1 wherein said difference-weighted output signal is a measure of the presence, absence, or degree of ischemia in an tissue for anastomosis.

13. The apparatus of claims 1 or 12, wherein at least one said output signal is configured to be a function of tissue hemoglobin or myoglobin saturation.

14. The apparatus of claims 1 or 12, wherein at least one said output signal is configured to be a function of angiogenesis.

15. The apparatus of claims 1 or 12, wherein at least one said output signal is configured to be a function of water and/or lipid content.

16. The apparatus of claims 1 or 12, wherein at least one said output signal is configured to be a function of the presence, absence, or degree of cancer.

11. A dual-sensor somatic tissue ischemia monitoring apparatus comprising:

a first locally-weighted ischemia sensor system configured to generate, based upon said light detected by a first sensor, a first output signal that is a function of the presence or degree of local tissue ischemia or cancer at said first target site;

a second locally-weighted ischemia sensor system configured to generate, based upon said light detected by a second sensor, a second output signal that is a function of the presence or degree of local tissue ischemia or cancer at said second target site; and

a display unit configured to display or allow near or substantially simultaneous comparison of said signals of said first target site relative to said second target site.

12. A difference-weighted spectroscopic somatic monitoring apparatus comprising:

a first through Nth sensor configured to generate, based upon light produced and/or detected by said first through Nth sensor, a first through Nth somatic output signal, each said first through Nth output signals arranged to be a function of a first through Nth spectroscopic measurement of a first through Nth somatic target site; and

,

a difference unit configured to compare at least two of said first through Nth somatic signals, and to generate a difference-weighted output signal based upon said comparison.

17. A method of monitoring or detecting tissue ischemia in a living tissue comprising the steps of:

generating a first somatic output signal based upon light produced and/or detected by a first sensor, said first somatic output signal being a function of the optical characteristics of a first somatic target site;

generating a second somatic output signal based upon light produced and/or detected by a second sensor, said second somatic output signal being a function of the optical characteristics of a second somatic target site; and

,

determining a difference by comparing said first and second somatic signals, and generating a difference output signal based upon said comparison.

18. The method of claim 17 further comprising:

taking interventional medical action based upon said detected signal; and

repeating said steps as required.

19. A difference-weighted spectroscopic monitoring apparatus comprising:

a sensor configured to generate, based upon light produced and/or detected by said sensor, at least a first and second output signal that are each a function of a spectroscopic measurement of a target site; and

,

a difference unit configured to compare said first and second signals, and to generate a difference-weighted signal based upon said comparison,

wherein said first signal is an estimate of arterial saturation and said second signal is an estimate of tissue or venous saturation, and said difference-weighted signal is a function of the perfusion of said target site.

20. A perfusion-sensitive difference-weighted spectroscopic monitoring apparatus comprising:

a sensor configured to generate, based upon light produced and/or detected by said sensor, at least a first and second output signal that are each a function of a spectroscopic measurement of a target site; and

,

a difference unit configured to compare said first and second signals, and to generate a difference-weighted signal based upon said comparison, wherein said difference-weighted signal is an estimate or function of a perfusion of said target site.

22. The device of claim 20 or 21, wherein said output signal is selected from the list of perfusion-sensitive determinations, estimates, or functions, based upon said difference-weighted signals, selected from the list of determinations consisting of cardiac output, vascular flow or resistance to flow, and venous saturation, arterial saturation, or arterial-venous saturation difference, an estimate or function of a difference in blood flow or other differences between two sites, a perfusion index, a magnitude of the time-varying signal, and other perfusion-sensitive measures or functions.

23. The device of claim 20 or 21, wherein said output signal is the presence, absence, or degree of a diagnosis selected from a list of perfusion-related diagnoses consisting of infection (sepsis), tissue rejection (host vs, graft disease), heat attack (myocardial ischemia), stroke (cerebral ischemia), local or systemic ischemia, acute or chronic organ failure, diabetic peripheral vascular disease, and other perfusion-related conditions.

21. A device for determining a difference-weighted perfusion in a tissue, the device comprising:

a light source for illuminating a target;

a light sensor configured to detect light scattered by the target onto said sensor; and

,

a difference unit for generating, based on the light detected by the sensor, an output signal that is a function of a difference-weighted measure of perfusion of said tissue.